103 related articles for article (PubMed ID: 8816581)
41. [Differential malignant lymphoproliferative syndrome (LPS) diagnosis with flow cytometry: a study of 100 patients].
Cardile N; Sabo G; Butsch P; Brengarth E; Viollier AF; Knecht H
Praxis (Bern 1994); 2000 Jan; 89(4):143-9. PubMed ID: 10686807
[TBL] [Abstract][Full Text] [Related]
42. Tissue-specific expansion of NKT and CD5+B cells at the onset of autoimmune disease in (NZBxNZW)F1 mice.
Morshed SR; Mannoor K; Halder RC; Kawamura H; Bannai M; Sekikawa H; Watanabe H; Abo T
Eur J Immunol; 2002 Sep; 32(9):2551-61. PubMed ID: 12207339
[TBL] [Abstract][Full Text] [Related]
43. Flow cytometric immunophenotyping in posttransplant lymphoproliferative disorders.
Dunphy CH; Gardner LJ; Grosso LE; Evans HL
Am J Clin Pathol; 2002 Jan; 117(1):24-8. PubMed ID: 11789726
[TBL] [Abstract][Full Text] [Related]
44. Clinical and phenotypic features of CD5-negative B cell chronic lymphoproliferative disease resembling chronic lymphocytic leukemia.
Romano C; Sellitto A; Chiurazzi F; Simeone L; De Fanis U; Raia M; Del Vecchio L; Lucivero G
Int J Hematol; 2015 Jan; 101(1):67-74. PubMed ID: 25432435
[TBL] [Abstract][Full Text] [Related]
45. Isotype and antibody specificity of spontaneously formed immunoglobulins in pig fetuses and germ-free piglets: production by CD5- B cells.
Cukrowska B; Sinkora J; Reháková Z; Sinkora M; Splíchal I; Tucková L; Avrameas S; Saalmüller A; Barot-Ciorbaru R; Tlaskalová-Hogenová H
Immunology; 1996 Aug; 88(4):611-7. PubMed ID: 8881765
[TBL] [Abstract][Full Text] [Related]
46. In situ hybridization analysis of lymphoproliferative disorders. Assessment of clonality by immunoglobulin light-chain messenger RNA expression.
Segal GH; Shick HE; Tubbs RR; Fishleder AJ; Stoler MH
Diagn Mol Pathol; 1994 Sep; 3(3):170-7. PubMed ID: 7981892
[TBL] [Abstract][Full Text] [Related]
47. CD33 detection by immunohistochemistry in paraffin-embedded tissues: a new antibody shows excellent specificity and sensitivity for cells of myelomonocytic lineage.
Hoyer JD; Grogg KL; Hanson CA; Gamez JD; Dogan A
Am J Clin Pathol; 2008 Feb; 129(2):316-23. PubMed ID: 18208813
[TBL] [Abstract][Full Text] [Related]
48. Discordant immunophenotype of chronic B-cell lymphoproliferative disorders in simultaneous specimens from bone marrow and peripheral sites.
Liu YC; Cleveland RP; Madelaire C; Hines JD
Arch Pathol Lab Med; 1995 Jan; 119(1):53-8. PubMed ID: 7802554
[TBL] [Abstract][Full Text] [Related]
49. Cost-effective approach to the diagnostic workup of B cell lymphoproliferative disorders via optimal integration of flow cytometric data.
Mason EF; Morgan EA; Pinkus GS; Pozdnyakova O
Int J Lab Hematol; 2017 Apr; 39(2):137-146. PubMed ID: 28133951
[TBL] [Abstract][Full Text] [Related]
50. The diagnostic value of CD1d expression in a large cohort of patients with B-cell chronic lymphoproliferative disorders.
Kotsianidis I; Nakou E; Spanoudakis E; Bouchliou I; Moustakidis E; Miltiades P; Vadikolia CM; Szydlo R; Karadimitris A; Tsatalas C
Am J Clin Pathol; 2011 Sep; 136(3):400-8. PubMed ID: 21846915
[TBL] [Abstract][Full Text] [Related]
51. Immunophenotypic and immunogenotypic approaches useful in distinguishing benign and malignant lymphoid proliferations.
Knowles DM
Semin Oncol; 1993 Dec; 20(6):583-610. PubMed ID: 8296197
[TBL] [Abstract][Full Text] [Related]
52. Immunophenotyping of lymphomas and leukemias in paraffin-embedded tissues.
Perkins SL; Kjeldsberg CR
Am J Clin Pathol; 1993 Apr; 99(4):362-73. PubMed ID: 8475901
[No Abstract] [Full Text] [Related]
53. A6--a new 45RO monoclonal antibody for immunostaining of paraffin-embedded tissues.
Berti E; Aversa GG; Soligo D; Cattoretti G; Delia D; Aiello A; Parravicini C; Hall BM; Caputo R
Am J Clin Pathol; 1991 Feb; 95(2):188-93. PubMed ID: 1825147
[TBL] [Abstract][Full Text] [Related]
54. Immunophenotyping of lymphoproliferative disorders: state of the art.
Gudgin EJ; Erber WN
Pathology; 2005 Dec; 37(6):457-78. PubMed ID: 16373227
[TBL] [Abstract][Full Text] [Related]
55. [Immunologic study of lymphoproliferative diseases].
Cabrera ME; Majlis A; Labra S; Carrasco AM
Rev Med Chil; 1992 Jul; 120(7):772-7. PubMed ID: 1341818
[TBL] [Abstract][Full Text] [Related]
56. The CD45 isoform B220 identifies select subsets of human B cells and B-cell lymphoproliferative disorders.
Rodig SJ; Shahsafaei A; Li B; Dorfman DM
Hum Pathol; 2005 Jan; 36(1):51-7. PubMed ID: 15712182
[TBL] [Abstract][Full Text] [Related]
57. A scoring system for the classification of CD5-B CLL versus CD5+ B CLL and B PLL.
Salomon-Nguyen F; Valensi F; Merle-Beral H; Flandrin G
Leuk Lymphoma; 1995 Feb; 16(5-6):445-50. PubMed ID: 7540458
[TBL] [Abstract][Full Text] [Related]
58. Deciphering leukemic B-cell chronic lymphoproliferative disorders.
Ugo V; Leporrier N; Salaun V; Letestu R; Radford-Weiss I; Ramond S; Nataf J; Guesnu M; Picard F; Brouzes C; Perrot JY; Valensi F; Levy V; Ajchenbaum-Cymbalista F; Troussard X
Leuk Lymphoma; 2006 Oct; 47(10):2088-95. PubMed ID: 17071481
[TBL] [Abstract][Full Text] [Related]
59. Immunophenotypic diagnosis of non-Hodgkin's lymphoma in paraffin sections. Co-expression of L60 (Leu-22) and L26 antigens correlates with malignant histologic findings.
Ngan BY; Picker LJ; Medeiros LJ; Warnke RA
Am J Clin Pathol; 1989 May; 91(5):579-83. PubMed ID: 2718958
[TBL] [Abstract][Full Text] [Related]
60. Epidermotropic CD8 positive lymphoproliferative diseases: histological and immunophenotypic similarities but markedly differing clinical behaviour.
Paton DJ; Van Vliet C; Prasad Kumarasinghe S; Chan JJ; Wood BA
Pathology; 2016 Dec; 48(7):733-736. PubMed ID: 27814904
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
